CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 65 enrolled
Drug / intervention
Paroxetinedrug
Likely dose
Paroxetine 40mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00700999
NCT00700999Phase 4Completed
CompareCT.gov

Neurofunctional Markers of SSRI Treatment Response in PTSD

US Department of Veterans Affairs·interventional·Posted Jun 19, 2008·Updated Jun 3, 2014

In Brief

A Phase 4 clinical trial evaluating Paroxetine for Post-traumatic Stress Disorder. Completed, enrolled 65 participants across 3 sites.

Detailed Summary

The purpose of this study is to examine if treatment of post-traumatic stress disorder in combat veterans with paroxetine changes brain responses as measured by functional magnetic resonance imaging and if brain responses can predict who will get better with treatment.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPost-traumatic Stress Disorder
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJun 19, 2008
Enrollment StartOct 1, 2008
Primary CompletionMar 1, 2012
TodayJul 2, 2026
Enrollment to primary: 3.4 yearsPosted 18.0 years ago

Interventions

Paroxetinedrug

Paroxetine 20-40mg po QD for 12 weeks